NOVAVAX INC Uncategorized Contracts & Agreements
37 Contracts & Agreements
- Offer Letter to (Filed With SEC on February 28, 2024)
- Offer Letter to Elaine OHara dated (Filed With SEC on February 28, 2024)
- Offer letter to (Filed With SEC on February 28, 2024)
- Description of the Company's Securities (Filed With SEC on February 28, 2024)
- Description of the Company's Securities (Filed With SEC on February 28, 2023)
- Novavax, Inc. 2023 Inducement Plan (Filed With SEC on January 9, 2023)
- Amendment of Solicitation/Modification of Contract No. 4, dated as of July 29, 2022, between the Company. and the U.S. Department of Defense Joint Program Executive Office for... (Filed With SEC on November 9, 2022)
- Description of (Filed With SEC on March 1, 2022)
- Offer letter to James P. Kelly dated July (Filed With SEC on November 5, 2021)
- Offer letter to Gregory F. Covino dated October 30, 2020 (Filed With SEC on March 1, 2021)
- Description of Registrants Securities (Filed With SEC on March 1, 2021)
- Letter Contract, entered into on June 8, 2020, by and between the Company and the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological... (Filed With SEC on August 10, 2020)
- Description of Registrants Securities (Filed With SEC on March 11, 2020)
- NOVAVAX, INC. AMENDED AND RESTATED CHANGE IN CONTROLSEVERANCE BENEFIT PLAN Adopted by the Board of Directors August10, 2005 Amended by the Board of Directors July26, 2006 Amended... (Filed With SEC on February 27, 2017)
- JPMorgan Chase Bank, National Association Organised under the laws of the United Statesas a National Banking Association. Main Office 1111 Polaris Parkway, Columbus,Ohio 43240... (Filed With SEC on February 29, 2016)
- W I T N E S S E T H: (Filed With SEC on February 29, 2016)
- JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on January 29, 2016)
- [**] = Portions of this exhibit have been omittedpursuant to a confidential treatment request. An unredacted version of this exhibit has beenfiled separately with the Commission. (Filed With SEC on November 9, 2015)
- Exhibit 10.1 (Filed With SEC on November 14, 2011)
- Guidelines On Significant Corporate Governance Issues Effective January 1, 2011 (Filed With SEC on May 10, 2011)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on May 10, 2011)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on May 10, 2011)
- 6,800,000 Shares and 1,020,000 Over-Allotment Shares (Filed With SEC on November 20, 2009)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on November 9, 2009)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on November 9, 2009)
- NOVAVAX, INC. (Filed With SEC on January 5, 2009)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTEDMATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on February 25, 2008)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on February 25, 2008)
- THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF ACONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH[* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 16, 2007)
- NOVAVAX, INC. (Filed With SEC on November 14, 2006)
- [Letterhead of Pharmelle, LLC] (Filed With SEC on November 14, 2006)
- Part I. Financial Information (Filed With SEC on August 13, 2003)
- [Novavax Letterhead] (Filed With SEC on August 14, 2002)
- [Novavax Letterhead] (Filed With SEC on August 14, 2002)
- Agreement of Lease-W.M.Rickman Construction Co (Filed With SEC on March 15, 2002)
- SECOND AMENDMENT TO THE COPROMOTION AGREEMENT (Filed With SEC on August 13, 2001)
- FIRST AMENDMENT TO THE COPROMOTION AGREEMENT (Filed With SEC on August 13, 2001)
